Standard BioTools Inc. Cost of Goods Sold (Deprecated 2018-01-31)
Standard BioTools Inc. (LAB) reported Cost of Goods Sold (Deprecated 2018-01-31) of $11.16 million for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-08-08.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsSold · last filed 2018-08-08
- Standard BioTools Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-06-30 was $11.16M, a 3.39% increase year-over-year.
- Standard BioTools Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $10.22M, a 5.80% decline year-over-year.
- Standard BioTools Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $11.98M, a 19.63% increase year-over-year.
- Standard BioTools Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $11.41M, a 25.83% increase year-over-year.
- Standard BioTools Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $45.04M, a 9.56% increase from fiscal 2016.
- Standard BioTools Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $41.11M, a 4.40% decline from fiscal 2015.
- Standard BioTools Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $43.00M, a 8.83% increase from fiscal 2014.
- Standard BioTools Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $39.51M, a 113.14% increase from fiscal 2013.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 3 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 12 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-06-30 | $11.16M 10-Q · filed 2018-08-08 | $21.38M 10-Q · filed 2018-08-08 | $33.36M derived: sum of 3 quarters · filed 2018-08-08 | $44.77M derived: sum of 4 quarters · filed 2018-08-08 | ||||
| 2018-03-31 | $10.22M 10-Q · filed 2018-05-08 | $22.20M derived: sum of 2 quarters · filed 2018-05-08 | $33.62M derived: sum of 3 quarters · filed 2018-05-08 | $44.41M derived: sum of 4 quarters · filed 2018-08-08 | ||||
| 2017-12-31 | $11.98M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $23.39M derived: sum of 2 quarters · filed 2018-03-08 | $34.19M derived: sum of 3 quarters · filed 2018-08-08 | $45.04M 10-K · filed 2018-03-08 | ||||
| 2017-09-30 | $11.41M 10-Q · filed 2017-11-07 | $22.21M derived: sum of 2 quarters · filed 2018-08-08 | $33.06M 10-Q · filed 2017-11-07 | $43.07M derived: sum of 4 quarters · filed 2018-08-08 | ||||
| 2017-06-30 | $10.79M 10-Q · filed 2018-08-08 | $21.64M 10-Q · filed 2018-08-08 | $31.66M derived: sum of 3 quarters · filed 2018-08-08 | $40.73M derived: sum of 4 quarters · filed 2018-08-08 | ||||
| 2017-03-31 | $10.85M 10-Q · filed 2018-05-08 | $20.86M derived: sum of 2 quarters · filed 2018-05-08 | $29.93M derived: sum of 3 quarters · filed 2018-05-08 | $41.17M derived: sum of 4 quarters · filed 2018-05-08 | ||||
| 2016-12-31 | $10.01M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $19.08M derived: sum of 2 quarters · filed 2018-03-08 | $30.32M derived: sum of 3 quarters · filed 2018-03-08 | $41.11M 10-K · filed 2018-03-08 | ||||
| 2016-09-30 | $9.07M 10-Q · filed 2017-11-07 | $20.31M derived: sum of 2 quarters · filed 2017-11-07 | $31.10M 10-Q · filed 2017-11-07 | $42.59M derived: sum of 4 quarters · filed 2018-03-08 | ||||
| 2016-06-30 | $11.24M 10-Q · filed 2017-08-08 | $22.03M 10-Q · filed 2017-08-08 | $33.52M derived: sum of 3 quarters · filed 2018-03-08 | $43.98M derived: sum of 4 quarters · filed 2018-03-08 | ||||
| 2016-03-31 | $10.79M 10-Q · filed 2017-05-09 | $22.28M derived: sum of 2 quarters · filed 2018-03-08 | $32.74M derived: sum of 3 quarters · filed 2018-03-08 | $43.90M derived: sum of 4 quarters · filed 2018-03-08 | ||||
| 2015-12-31 | $11.49M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $21.95M derived: sum of 2 quarters · filed 2018-03-08 | $33.11M derived: sum of 3 quarters · filed 2018-03-08 | $43.00M 10-K · filed 2018-03-08 | ||||
| 2015-09-30 | $10.46M 10-Q · filed 2016-11-09 | $21.62M derived: sum of 2 quarters · filed 2016-11-09 | $31.51M 10-Q · filed 2016-11-09 | $43.26M derived: sum of 4 quarters · filed 2017-03-03 | ||||
| 2015-06-30 | $11.16M 10-Q · filed 2016-08-09 | $11.96M 10-Q · filed 2015-08-10 | $21.05M 10-Q · filed 2016-08-09 | $22.61M 10-Q · filed 2015-08-10 | $32.80M derived: sum of 3 quarters · filed 2017-03-03 | $43.36M derived: sum of 4 quarters · filed 2017-03-03 | ||
| 2015-03-31 | $9.89M 10-Q · filed 2016-05-09 | $10.65M 10-Q · filed 2015-05-11 | $21.64M derived: sum of 2 quarters · filed 2017-03-03 | $32.20M derived: sum of 3 quarters · filed 2017-03-03 | $42.16M derived: sum of 4 quarters · filed 2017-03-03 | |||
| 2014-12-31 | $11.75M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $22.31M derived: sum of 2 quarters · filed 2017-03-03 | $32.27M derived: sum of 3 quarters · filed 2017-03-03 | $39.51M 10-K · filed 2017-03-03 | $42.85M 10-K · filed 2015-02-26 | |||
| 2014-09-30 | $10.56M 10-Q · filed 2015-11-09 | $11.42M 10-Q · filed 2014-11-06 | $20.51M derived: sum of 2 quarters · filed 2015-11-09 | $27.76M 10-Q · filed 2015-11-09 | $30.08M 10-Q · filed 2014-11-06 | $33.48M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-06-30 | $9.96M 10-Q · filed 2015-08-10 | $18.66M 10-Q · filed 2015-08-10 | $22.92M derived: sum of 3 quarters · filed 2016-02-29 | $28.06M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | $8.70M 10-Q · filed 2015-05-11 | $12.97M derived: sum of 2 quarters · filed 2016-02-29 | $18.11M derived: sum of 3 quarters · filed 2016-02-29 | $22.98M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $4.26M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $9.40M derived: sum of 2 quarters · filed 2016-02-29 | $14.28M derived: sum of 3 quarters · filed 2016-02-29 | $18.54M 10-K · filed 2016-02-29 | $20.20M 10-K · filed 2014-03-12 | |||
| 2013-09-30 | $5.14M 10-Q · filed 2014-11-06 | $10.01M derived: sum of 2 quarters · filed 2014-11-06 | $14.27M 10-Q · filed 2014-11-06 | $18.61M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2013-06-30 | $4.88M 10-Q · filed 2014-08-04 | $9.13M 10-Q · filed 2014-08-04 | $13.47M derived: sum of 3 quarters · filed 2015-02-26 | $16.99M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2013-03-31 | $4.26M 10-Q · filed 2014-05-12 | $8.59M derived: sum of 2 quarters · filed 2015-02-26 | $12.11M derived: sum of 3 quarters · filed 2015-02-26 | $16.04M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2012-12-31 | $4.33M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $7.85M derived: sum of 2 quarters · filed 2015-02-26 | $11.78M derived: sum of 3 quarters · filed 2015-02-26 | $15.32M 10-K · filed 2015-02-26 | ||||
| 2012-09-30 | $3.52M 10-Q · filed 2013-11-07 | $7.44M derived: sum of 2 quarters · filed 2013-11-07 | $10.99M 10-Q · filed 2013-11-07 | $15.00M derived: sum of 4 quarters · filed 2014-03-12 | ||||
| 2012-06-30 | $3.93M 10-Q · filed 2013-08-07 | $7.47M 10-Q · filed 2013-08-07 | $11.48M derived: sum of 3 quarters · filed 2014-03-12 | $14.79M derived: sum of 4 quarters · filed 2014-03-12 | ||||
| 2012-03-31 | $3.55M 10-Q · filed 2013-05-09 | $7.55M derived: sum of 2 quarters · filed 2014-03-12 | $10.86M derived: sum of 3 quarters · filed 2014-03-12 | $13.82M derived: sum of 4 quarters · filed 2014-03-12 | ||||
| 2011-12-31 | $4.01M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-12 | $7.31M derived: sum of 2 quarters · filed 2014-03-12 | $10.28M derived: sum of 3 quarters · filed 2014-03-12 | $13.19M 10-K · filed 2014-03-12 | ||||
| 2011-09-30 | $3.31M 10-Q · filed 2012-11-09 | $6.27M derived: sum of 2 quarters · filed 2012-11-09 | $9.18M 10-Q · filed 2012-11-09 | $12.77M derived: sum of 4 quarters · filed 2013-03-12 | ||||
| 2011-06-30 | $2.96M 10-Q · filed 2012-08-14 | $5.88M 10-Q · filed 2012-08-14 | $9.46M derived: sum of 3 quarters · filed 2013-03-12 | $11.91M derived: sum of 4 quarters · filed 2013-03-12 | ||||
| 2011-03-31 | $2.91M 10-Q · filed 2012-05-15 | $6.50M derived: sum of 2 quarters · filed 2013-03-12 | $8.95M derived: sum of 3 quarters · filed 2013-03-12 | $11.85M derived: sum of 4 quarters · filed 2013-03-12 | ||||
| 2010-12-31 | $3.58M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | $6.04M derived: sum of 2 quarters · filed 2013-03-12 | $8.94M derived: sum of 3 quarters · filed 2013-03-12 | $11.58M 10-K · filed 2013-03-12 | ||||
| 2010-09-30 | $2.45M 10-Q · filed 2011-11-14 | $5.35M derived: sum of 2 quarters · filed 2011-11-14 | $8.00M 10-Q · filed 2011-11-14 | |||||
| 2010-06-30 | $2.90M 10-Q · filed 2011-08-09 | $5.54M 10-Q · filed 2011-08-09 | ||||||
| 2009-12-31 | $11.49M 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |